ChatGPT SearchJun 25, 2026
CureRadar focuses on biomarker-driven matching of cancer patients to clinical trials and precision-oncology treatment options
Loading…
CureRadar provides an AI-driven platform that matches cancer patients to precision oncology clinical trials based on their specific genomic biomarkers and treatment history. The service extracts patient data from medical reports to generate professional briefings that help patients discuss trial eligibility with their oncologists.
AI named CureRadar in June 2026.
Question: Which startups help doctors use patient-specific diagnostics to choose treatments earlier?
ChatGPT SearchJun 25, 2026
CureRadar focuses on biomarker-driven matching of cancer patients to clinical trials and precision-oncology treatment options
AI cited cureradar.com in these answers, after aitiologic.com and avenir.tech.
cureradar.com 9%Other sites 91%
Excerpts where CureRadar appeared in the AI's answer
CureRadar focuses on biomarker-driven matching of cancer patients to clinical trials and precision-oncology treatment options
